CR4 pharmacology Flashcards

(83 cards)

1
Q

Indications to the uses of Nitrates

A

All types of Angina, acute angina attack (immediate release), prophylactic treatment (long acting)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

MOA low dose nitrates

A

Reduce preload but causing venous vasodilation (reduces the oxugen demand)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

MOA high dose nitrates

A

Arterial dilation - reduces afterload and increases O2 supply

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what enzyme converts Nitroglycerin to NO2

A

Aldehyde dehydrogenase - this is a problem in asians who do not have this enzyme- they cannot take nirtoglycerin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what enzyme converts NO2 to NO

A

P450 dehydrogenase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Acute AE of nitrates

A

headache, flushing, orthostatic hypotension, dizziness, syncope, REFLEX TACH, paradoxical bradycardia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Chronic AE of nitrates

A

NITRATE TOLERANCE , dependence withdrawl, Methemoglobinemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Nitrate DDI (major)

A

PDE inhibitors (-fils) - can cause major hypotension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Nitrate metabolism

A

high first pass metabolism (cant be taken orally)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Nitrate contraindications

A

Hypotension (SBP <100), elevated intracranial pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

PDE inhibitor uses

A

Erectile dysfunction, Pulmonary HTN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

MOA PDE inhibitor

A

enhabce the effect of NO on smooth muscle by allowing degradation of cGMP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

PDE inhibitor AE

A

mainly due to vasodilatriy effects, visual disturbances

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

First line drug for stable angina

A

Beta blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

First line drug for unstable angina

A

Beta blocker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

First line drug for the prevention/decreasing frequencty of anginal attacks

A

Beta blocker- has survival benefits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

drug for exercise induced angina

A

Beta Blocker (remember a side effect is exercise intolerance)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

which BB have vasodilatory effects, what are these effects

A

Lebetilol and Cavedilol - block alpha receptors by reducing IP3 generation in vascular smooth muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Which BB have intrisic sympathomemetic activity, what are these effects

A

Pindolol, Acebutolol - partial B1 and B2 agonists (enough stimulation that they are tolerable)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Which BB has B3 receptor agonist activity

A

Nebivolol - enchances NO production (may relieve erectile dysfunction)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

BB major DDI

A

Insulin, hyperglycemic agents, verapamil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Lipid soluble BB metabolism

A

Propranolol and Metoprolol are metabolized by the liver (CYP2D6)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Hydrophilic BB metabolism

A

Nadalol and atenolol - renal excretion unchanged

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

discontinuation of BB

A

over 2 week period to prevent refelex vasoconstriction that can worsen cardiac ischemia - can be mitigated by using a CaBlocker (dihydropyradine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
BB are contraindicated in what form of angina
Varient (Prinzmetal) - can potentiate vasoconstriction as a result of unopposed alpha adrenergic activity in coronary smooth muscle
26
BB Contraindications
variant angina, asthma, raynauds, AV block, Bradycardia, depression
27
Indications for the use of calcium channel blockers
1: Stable or variant angina 2: Can prevent angina but do not have the survival benefits that beta blockers do - used as a monotherapy when BB are contraindicated 3: Add on therapy to BB when theraputic goals are not being met (Dihdyrdopydradines) **THIS IS MORE EFFECTIVE THAN USING EACH DRUG ALONE
28
Non-dihydropyridines MOA
Dilt and Verapamil - Reduce voltage dependent L-type calcium channels in cardiac muscle - slow conduction through AV node (prevents Ca channel recovery) - decreased contractility due to decrease in calcium - relax nonvascular smooth muscle (Bronchial, GI, Uterine)
29
Dihydropyridine MOA
Pines - reduce voltage gated L-type calcium in smooth musle cells. effective vasodilatirs therfore decrease PR and BP (afterload)
30
Calcium channel blocker AE
Short acting result in HYPOTENSION, REFLEX TACH, RISK OF MI, peripheral edema, headache, flushing, nausea . Long term results in PERIPHERAL EDEMA
31
Non-dihydropyridines DDI
Beta blockers (can induce severe Bradycardia) , increase [Digoxin]
32
Dihydropyridine DDI
These drugs do not produced DDI because they are not block or induce CYP34A - other drugs can affect the concentrtaion of dihydropyradines
33
Non-dihydropyridines Metabolism
CYP3A4, block p-glycoprotein
34
Dihydropyridine Metabolism
CYP3A4
35
Non-dihydropyridine Contraindications
HF, AV conduction problems, Sick Sinus Syndrome, Hypotension, Aortic Stenosis
36
Dihydropyridine contraindications
Hyptension, aortic stenosis
37
Indication for use of Ranolazine
Stable angina as an add on agent if preventative goals have not been achieved. Combination therapy with nitrates, BB, or dihydropyradines. Can be used as BB alternative in contraindications and AE
38
Ranolazine MOA
blocks cardiac late Na channels - revereses the effect of Na buidup that occurs in ischemia and assures NCX goes in the correct direction (Na in Ca out)
39
Ranolazine AE
Long QT syndrome (due to block of Ikr)
40
Ranolazine DDI
Verapamil and Diltiazem, Ketoconazole (CYP34a blockers), Inhibits metabolism of digoxin and simvastatin (dose adjust these drugs)
41
in addition to anginal tretemt all patients should begin …
1: Antiplatelet (Asprin) 2: Antihypertensive (Atorvastatin)
42
what classes are used in unstable angina
Beta blockers and nitrates
43
What classes are used in variant angina
Nitrtes and Calcium channel blockers
44
ACE-I MOA
suppress RAAS systme -- reduced preload and afterload (relaxation og blood vessels, reduce fluid and sodium retention) and inhibit remodeling
45
First choice treatment for CHF
ACE - used in all patients with HFrEF (reduces mortality up to 6 months)
46
ACE -I AE
GI, headache, dizziness, hypotension, HYPERKALEMIA, hypoglycemia, renal function impairment, ANGIOEDEMA, **COUGH
47
ACE-I CI
Pregnancy, bilateral renal stenosis - less effective in black population
48
Clinical use of ARB
used as an alternative only in patients who cannot tolerate ACE
49
Patient presents with NYHA II and EF 30%. Current medications include an ace and an a beta blokcer. The patinet remains symptomatic. What drug do you give to reduce mortality and cardiac remodeling
Aldosterone receptor antagonist (Spiralactone eperenone)
50
Patinet has syptoms of HF and LVEF < 40% with a history of diabetes what drug would you give
Aldosterone receptor antagonist (Spiralactone eperenone)
51
Aldosterone receptor antagonits major AE
HYPERKALEMIA, ACIDOSIS , gynecomatasia
52
Aldosterone receptor antagonist DDI
Oral K, other K sparing diuretics, NSAIDS
53
Aldosterone receptor antagonist CI
Renal isnufficiency, Serum K >5
54
BB MOA
reduced workload of the heart, decreased HR and contractility. Prevent RAAS activation- prevent fluid retention and remodeling. Reduce cardiac remodeling and mortality
55
BB Indication
Anyone with HFrEF on standard thearpy (ACE and diuretic as needed) who are hemodynamically stable (NO HYPOTENSION)
56
BB AE
Bradycardia (decreased HR), reduced exercise tolerance, fluid retention, worsening HF, hypotension
57
BB DDI
Digoxin
58
BB CI
Unstable HF, severe bradycardia, and heart block. Carvedilol should not be used in patients with asthma and COPD
59
Which drug can replace ACE in patient who can tolerate ARBs and are NYHA II or III
ARNI (sacubitril and valsartan: further reduce morbidity and mortality) Enhance the action of NP and supress the effect of Ang II
60
ARNI AE
Hypotension, Hyperkalemia, renal impairment
61
ARNI DDI
RAAS inhibitors
62
ARNI CI
pregnancy, bilateral renal stenosis , HX OF ANGIOEDEMA
63
47 year old african american female (ACE/ARB intoleranct) presents with NYHA III HFrEF who is symptomatic on standard therapy. What durg should be given
Hyrdralazine+ Isorbide (arteial and venous dilators)
64
Vasodilator CI
PDE inhibitors and Hypotension
65
Most common side effect of vasodilators
Flushing - also cause headache, postural hypotension, reflex tach, fluid retention and LUPUS ERYTHEMATOSUS LIKE SYNDROME
66
Loop diretic MOA
Relive pulmonary and peripheral congestion by inhibiting Na/K/2Cl in the thick ascending limb of the loop of henle and promoting renal loss of sodium and water
67
First line for rapid relief of congestion symptoms in HF
Loop Diuretic
68
Major AE of Loop Diuretics
Alkalosis, HYPOKALEMIA , Dilutional hyponatremia, ** Ototoxicity
69
Digoxin MOA
ionotropic drug. Inhibits Na/K ATPase -- slows down the NaCa exchange thereby increasing the amount of Ca in the cell - increases contractility. At theraputic doses it slows HR and increases Contractility
70
Patient presents with symptomatic HFrEF. They are currently taking ACE, BB, aldosterone receptor blocker, and diuretic. What drug do you give
Digoxin
71
Patient presents with CHF and atrial fibrillation - what drug do you give
Digoxin
72
Patient complains of bludrred vision,altered color perception and hallows around dark objects- what drug are they taking
Digoxin
73
Digoxin DDI
Diuretics, CCB, BB
74
Patient is experiencing Digoxin toxicity - how do you treat
Lower or discontinue digoxin, correct electrolyte abnormalities (Mg, K) treat arrythmia with antiarrythmic, and give Digibind to reverse toxicity
75
Beta adrenergic receptors used in heart failure
Dopamine and dobutamine
76
Dopamine and dobutamine MOA
Ionotropic agent. Bind to B1 receptor and increase CAMP and PKA to promote Ca release to increase cardiac contractility
77
Dopamine and dobutamine indication
short term for treating end stage heart failure - patients with systolic dysfunction who don’t respond to other therapies and have organ hypoperfusion. Also increases contractility in acute HF
78
dopamine and dobutamine AE
tachycardia and Arrythmia (due to increased Ca)
79
PDE inhibitors
Milrinone and Imamirone
80
what drugs are indicated in end stage heart failure
PDE inhibitors and Vasodilators (dopamine and dobutamine)
81
PDE inhibior indication
Shor term use in treating end stage heart failure- systolic dysfunction who don’t respond to other therapies and have end organ hypoprofusion
82
Ivabradine MOA
Slows HR by blocking the cardica pacemaker If current (funny channel)
83
Ivabradine Indication
Worsening HF in patients with stable symptomatic HF, LVEF <35% who are in sinus whythm with a resting HR >70 bpm and who are on maximum tolerated doses of BB or have a contraindication to BB